Our projects
Opening of the new CHUV Children’s Hospital: A historic milestone in paediatric medicine
The new Children’s Hospital opens on 14 May 2025 with the completion of a complex building project that started in 2019 in the heart of the Lausanne hospital complex.
Read more
Major breakthrough in the treatment of Parkinson’s disease
Neuroscientists and neurosurgeons at the EPFL/CHUV/UNIL, Inserm and the University of Bordeaux have designed a neuroprosthetic intended to correct walking disorders associated with Parkinson’s disease.
Read more
Improving your sleep can protect your cardiovascular health
Researchers at the CHUV and Inserm studied the risk of cardiovascular events related to sleep disorders. This study shows that five components of sleep have a significant impact on the risk of coronary events and strokes.
Read more
Brain Computer Interface enables thought-controlled walking after spinal cord injury
Neuroscientists and neurosurgeons from EPFL/CHUV/UNIL and CEA/CHUGA/UGA report that they have re-established the communication between the brain and spinal cord with a wireless digital bridge, allowing a paralyzed person to walk again naturally.
Read more
Pushing the Boundaries of Innovation for Brain Tumor Research
The neuro-oncology team at the CHUV is intensely involved in international and in-house clinical trials. Clinical trials represent an important opportunity for patients who can potentially benefit from the latest advances in the field.
Read more
Walking again: new implant offers promise for the paralyzed
A system developed by Grégoire Courtine and Jocelyne Bloch now enables patients with a complete spinal cord injury to stand, walk and even perform recreational activities like swimming, cycling and canoeing.
Read more
How does our brain produce dreams?
At our Center for Sleep Investigation and Research, Professor Francesca Siclari has been awarded two grants between 2021 and 2022, including a prestigious ERC Starting Grant, for her research on mechanisms at the origin of dreams.
Read more
Providing better support for people during a pandemic
The “Collaborative Outcomes Study on Health and Functioning during Infection Times” (COH-FIT), which involves almost 200 researchers from over 40 countries on six continents, aims to measure the impact of the COVID-19 on physical and mental health.
Read more
Predicting the severity of the illness using immune signatures
The research project “Defining the immune signatures in SARS-CoV-2 infected individuals in blood and tissues” aims to identity the biological markers that predict the severity of the illness.
Read more
Host determinants of severe COVID-19, learning from extreme cases
Supported by the SNF, this research project is based on the hypotheses that severe presentation of COVID-19 results from genetic predisposition and that transcriptomic profiling at an early stage may help predict adverse outcomes.
Read more
Identifying antibodies that can neutralise the coronavirus
As part of the “Corona Accelerated R&D in Europe” (CARE) programme, the Allergy and Immunology Department at CHUV has secured funding of almost 5 million Swiss francs for its work aimed at isolating antibodies that neutralise the coronavirus.
Read more
Coordinating the Swiss arm of “Solidarity”
Supported by the Swiss National Science Foundation (NSF) and in collaboration with the Federal Office of Public Health (FOPH), CHUV is coordinating Switzerland’s participation in the “Solidarity” study.
Read more
Developing the leading blood test for Switzerland
In conjunction with the École polytechnique fédérale de Lausanne (EPFL) and the Swiss Vaccine Research Institute (SVRI), CHUV has developed the blood test selected for conducting population studies in Switzerland.
Read more
Understanding the impact of COVID-19 on pregnancy
CHUV has created the “International COVID-19 and Pregnancy Registry” (COVI-Preg), which aims to assess the impact of SARS-CoV 2 on pregnancy and the health of mothers and newborns.
Read more
Tackling cancer treatment resistance with FLASH
FLASH radiotherapy is a new form of treatment pioneered by the CHUV Service of radiation oncology.
Read more
Adapting hospitals for our seniors
CHUV aims to turn itself into a more old patients-friendly hospital by 2023. Measures are planned to adapt the pace and type of care.
Read more
Healing severe burn victims
A pioneer in biological bandages for burn victims, CHUV now hopes to give them antimicrobial properties.
Read more
Uncovering the mysteries of lymph
Unique in Switzerland, CHUV’s lymphatic vessel imaging technique is improving treatments for lymphoedema.
Read more
Giving birth in a more natural position
Imaging, biomechanics and obstetrics professionals are joining forces to find the best positions for vaginal delivery.
Read more
Revealing the cause of death
Forensic imaging has taken a leap forward thanks to the post-mortem angiography technique developed at CHUV. Fluids flow through blood vessels without a beating heart.
Read more
Immunotherapy for children
To fight lymphoblastic leukaemia in children and young adults, the UNIL CHUV Oncology Department and our paediatric oncology consultation have developed an innovative immunotherapy in collaboration with Seattle Children's Hospital.
Read more
A close look at the Lausanne inhabitants
The CoLaus|PsyCoLaus study includes more than 6,700 inhabitants of the city of Lausanne in Switzerland followed for over 15 years. The results of the study have already given rise to more than 470 publications.
Read more